Business Context and Reporting Period
This Form 8-K Current Report was filed by Second Sight Medical Products, Inc. (trading symbol: EYES) on March 12, 2020, covering events occurring on March 8, 2020. The registrant is an emerging growth company incorporated in California. Note: The request metadata references "Vivani Medical, Inc.," but the filing text explicitly identifies the registrant as Second Sight Medical Products, Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial statements or performance metrics.
Material Changes
- Executive Departure: Will McGuire submitted his resignation as President and Chief Executive Officer, effective March 27, 2020.
- Board Status: Mr. McGuire remains a member of the Board of Directors following his departure from executive management.
- Leadership Appointment: Gregg Williams, Chairman of the Board, was appointed Acting Chief Executive Officer effective upon Mr. McGuire's departure.
- Reporting Structure: John T. Blake (CFO) and Pat Ryan (COO) will now report to Mr. Williams.
Outlook, Risks, and Management Commentary
The Board has initiated a search process to identify and recruit an experienced and qualified successor to the CEO position. The Company issued a press release on March 12, 2020, detailing these leadership changes. No specific financial guidance, risk factors, or contingencies were disclosed in this filing.
Investor Verification Checklist
- Verify the timeline for the CEO search and the expected duration of the interim leadership arrangement.
- Review the press release dated March 12, 2020 (Exhibit 99.1) for additional context on the resignation.
- Confirm the strategic direction of the company under the new Acting CEO, Gregg Williams.
- Monitor future filings for the appointment of a permanent CEO and any potential changes to the Board composition.